Intravesical Liposomes for Ulcerative Cystitis

NCT01083979 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2017-02-08

Study results available
· View outcomes & findings →

Summary

The objective is to instill liposomes reconstituted with sterile water into the bladder as a compassionate use treatment in one patient with ulcerative interstitial cystitis (IC).

Conditions

  • Interstitial Cystitis

Interventions

DRUG

Liposomes

Intravesical instillation

Sponsors & Collaborators

  • Kenneth Peters, MD

    lead OTHER

Principal Investigators

  • Kenneth M Peters, MD · William Beaumont Hospitals

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01083979 on ClinicalTrials.gov